ATE314094T1 - Ein komplex aus alpha-fetoprotein (afp) und einem polyungesättigten fettsäurederivat zur behandlung von immunschwäche - Google Patents

Ein komplex aus alpha-fetoprotein (afp) und einem polyungesättigten fettsäurederivat zur behandlung von immunschwäche

Info

Publication number
ATE314094T1
ATE314094T1 AT99931090T AT99931090T ATE314094T1 AT E314094 T1 ATE314094 T1 AT E314094T1 AT 99931090 T AT99931090 T AT 99931090T AT 99931090 T AT99931090 T AT 99931090T AT E314094 T1 ATE314094 T1 AT E314094T1
Authority
AT
Austria
Prior art keywords
afp
fetoprotein
alpha
complex
treatment
Prior art date
Application number
AT99931090T
Other languages
German (de)
English (en)
Inventor
Oleg Strelchenok
Original Assignee
Ardenia Investments Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ardenia Investments Ltd filed Critical Ardenia Investments Ltd
Application granted granted Critical
Publication of ATE314094T1 publication Critical patent/ATE314094T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99931090T 1998-06-17 1999-06-17 Ein komplex aus alpha-fetoprotein (afp) und einem polyungesättigten fettsäurederivat zur behandlung von immunschwäche ATE314094T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9802162A SE9802162D0 (sv) 1998-06-17 1998-06-17 Immunostimulating composition
PCT/EP1999/004201 WO1999065936A2 (en) 1998-06-17 1999-06-17 Composition for the treatement of immune deficiencies and methods for its preparation and use

Publications (1)

Publication Number Publication Date
ATE314094T1 true ATE314094T1 (de) 2006-01-15

Family

ID=20411743

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99931090T ATE314094T1 (de) 1998-06-17 1999-06-17 Ein komplex aus alpha-fetoprotein (afp) und einem polyungesättigten fettsäurederivat zur behandlung von immunschwäche

Country Status (10)

Country Link
US (1) US6599507B2 (enExample)
EP (1) EP1085909B1 (enExample)
JP (1) JP4392991B2 (enExample)
AT (1) ATE314094T1 (enExample)
AU (1) AU748838B2 (enExample)
BR (1) BR9911294B1 (enExample)
CA (1) CA2335079C (enExample)
DE (1) DE69929189T2 (enExample)
SE (1) SE9802162D0 (enExample)
WO (1) WO1999065936A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802162D0 (sv) 1998-06-17 1998-06-17 Nomet Management Services Bv Immunostimulating composition
SE9900941D0 (sv) * 1998-12-23 1999-03-16 Nomet Management Serv Bv Novel retinoic acid derivatives and their use
ATE243701T1 (de) * 1999-03-16 2003-07-15 Ardenia Investments Ltd Polyungesättigte fettsäurederivate und deren verwendung in der krebsbehandlung
WO2002004467A1 (en) * 2000-07-12 2002-01-17 Ardenia Investments Ltd. Novel cytotoxic compounds and their use
US20070111936A1 (en) * 2005-11-15 2007-05-17 Vladimir Pak Complex of alpha-fetoprotein and inducers of apoptosis for the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096863A (en) * 1996-08-23 2000-08-01 Regents Of The University Of Minnesota Self-assembling amphiphiles for construction of peptide secondary structures
SE9802162D0 (sv) 1998-06-17 1998-06-17 Nomet Management Services Bv Immunostimulating composition

Also Published As

Publication number Publication date
EP1085909A2 (en) 2001-03-28
EP1085909B1 (en) 2005-12-28
US6599507B2 (en) 2003-07-29
WO1999065936A3 (en) 2000-02-10
BR9911294B1 (pt) 2012-01-10
HK1035866A1 (en) 2001-12-14
BR9911294A (pt) 2002-01-02
AU748838B2 (en) 2002-06-13
SE9802162D0 (sv) 1998-06-17
JP2004500315A (ja) 2004-01-08
CA2335079A1 (en) 1999-12-23
WO1999065936A2 (en) 1999-12-23
JP4392991B2 (ja) 2010-01-06
AU4773499A (en) 2000-01-05
CA2335079C (en) 2008-01-08
DE69929189T2 (de) 2006-08-31
DE69929189D1 (de) 2006-02-02
US20010034324A1 (en) 2001-10-25

Similar Documents

Publication Publication Date Title
ATE321525T1 (de) Verwendung von konjugierten linolensaüren zur topischen behandlung von zellulitis
ATE231511T1 (de) Magnesium(-)hydroxycitrat, verfahren zur herstellung, anwendung und pharmazeutische zusammensetzungen, die sie enthalten
GB9807639D0 (en) Anti-inflammatory agents
ATE462428T1 (de) Behandlung von entzündlichen erkrankungen
DE60043692D1 (de) Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen
DE69434937D1 (de) Verfahren zur Herstellung von Leistungsbauteilen in MOS-Technologie
DE60000492D1 (de) Kosmetisches Verfahren zur Haarbehandlung mit Metallpartikeln zur Verbesserung des Haarglanzes
ATE415962T1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
EP1019057A4 (en) METHOD FOR THE PREVENTION AND TREATMENT OF ESTROGEN-INDUCED DISEASES AND DISORDERS
ATE330608T1 (de) Die verwendung von n-phenyl-2-pyrimidine-amine derivaten zur behandlung von entzündlichen erkrankungen
CA2157836A1 (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
YU47100A (sh) Novi derivati dihidroksiheksanoinske kiseline
ATE311871T1 (de) Verwendung von zinksalzen der konjugierten linoleinsäuren zur behandlung von hautkrankheiten
ATE172117T1 (de) Verwendung von trospiumchlorid zur herstellung eines arzneimittels zur behandlung von blasenkrankheiten
IS5505A (is) Notkun á blöndu díóls og alfa-hýdroxýsýru til að meðhöndla sjúkdóma sem lýsa sér í ofvexti í hornlagi húðþekju
DE69929189D1 (de) Ein Komplex aus Alpha-Fetoprotein (AFP) und einem polyungesättigten Fettsäurederivat zur Behandlung von Immunschwäche
DE60035693D1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
ZA844835B (en) Imidazol-2-yl mercapto alkanoic acids,process for producing the same and pharmaceutical preparations containing the same
SG147469A1 (en) Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
DE69130679D1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
DE59902666D1 (de) Edelfosin zur behandlung von hirntumoren
DE69838553D1 (de) Verfahren zur diagnose, prognose und behandlung von glaukom und verwandten erkrankungen
DE60115523D1 (de) Verfahren zur Herstellung von Wasserlöslichen Polysacchariden und zur Aufklärung von wässerigen lösungen die sie enthalten
ATE332905T1 (de) Verfahren zur herstellung von acylphosphinoxiden
ES8302016A1 (es) Procedimiento para tratar fracciones individuales de plasma sanguineo.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties